EpCAM (CD326) finding its role in cancer

por Baeuerle, P A, Gires, O
Publicado 2007

EpCAM (CD326) finding its role in cancer

por Baeuerle, P A, Gires, O
Publicado 2007

Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer

por Ruf, P, Gires, O, Jäger, M, Fellinger, K, Atz, J, Lindhofer, H
Publicado 2007

EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205

por Massoner, P, Thomm, T, Mack, B, Untergasser, G, Martowicz, A, Bobowski, K, Klocker, H, Gires, O, Puhr, M
Publicado 2014